Log In
BCIQ
Print this Print this
 

LG690

  Manage Alerts
Collapse Summary General Information
Company Opus Bio Inc.
DescriptionSomatic T cell therapy
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPreclinical
Standard IndicationGraft-versus-host disease (GvHD)
Indication DetailsTreat graft-versus-host disease (GvHD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today